Q2 2019 Earnings Call

[laughter].

Yeah, something like that the.

NSF fees and customer fees, so hopefully that will come back, especially of getting to the summer season.

We're still seeing a lot of interest from customers on the swap product to generate fees I think the FDA pipeline is strong so those being the big pieces hopefully title income picks up as we get into the summer season, but.

That heavily dependent on the east and when we do we do have.

We are studying other ways, we see their opportunities that's much detail really having opportunities to increase be in certain areas, where we havent focused ship Adele lots more to come on that.

Okay. Okay, that's great I'll leave it there thanks guys.

Thank you.

This concludes our question and answer session I would like to turn the conference back over to Kevin O'connor for any closing remarks.

Again, I just want to take a moment to thank everybody on the call to acknowledge right because I know I have number of employees on the on the call to thank them for their efforts.

Certainly.

We are disappointed in.

What happened with the long but.

I believe very strongly in the business prospects for BNP.

And look forward to continuing to have discussions with you our shareholders on how we move this company forward. So thank you and have a great day.

The conference is now concluded. Thank you for attending today's presentation you may now disconnect.